CaliPharms

(OTC) KGET

Current Price$0.00

Market Cap$11,900

Since IPO (2013)-100%

5 Year-100%

1 Year+0%

1 Month+0%

CaliPharms Financials at a Glance

Market Cap

$11,900

Revenue (TTM)

$112.47K

Net Income (TTM)

$6.39M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-30.72 (Low)

Dividend

$0.00

Beta (Volatility)

-30.72 (Low)

Price

$0.00

Volume

13,602,648

Open

$0.00

Price

$0.00

Volume

13,602,648

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

-30.72 (Low)

Price

$0.00

Volume

13,602,648

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

KGET News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CaliPharms

Industry

Machinery

Sector

Industrials

Headquarters

Temecula, 92592, US

KGET Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-112%

Net Income Margin

-119%

Return on Equity

Return on Capital

34%

Return on Assets

-75%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.90K

Shares Outstanding

11.86B

Volume

13.60M

Avg. Volume

553.96K

Financials (TTM)

Gross Profit

$12.00K

Operating Income

$1.35M

EBITDA

$1.35M

Operating Cash Flow

$162.21K

Capital Expenditure

$0.00

Free Cash Flow

$162.21K

Cash & ST Invst.

$6.49K

Total Debt

$361.75K

CaliPharms Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2014YOY CHG

Revenue

$59.96K

N/A

Gross Profit

$7.44K

N/A

Gross Margin

-12.41%

N/A

Market Cap

$11.90K

N/A

Market Cap/Employee

$2.98K

N/A

Employees

N/A

Net Income

$4.18M

-11286.6%

EBITDA

$231.56K

-25.5%

Quarterly Fundamentals

Name

Q3 2014YOY CHG

Net Cash

$205.39K

-8099.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$222.55K

+8682.7%

Return on Assets

-74.95%

N/A

Return on Invested Capital

34.01%

N/A

Free Cash Flow

$249.88K

-12332.0%

Operating Cash Flow

$249.88K

-12332.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MTMWMatmown, Inc.

MTMWMatmown, Inc.$0.00N/A

TFZIThe Fight Zone, Inc.

TFZIThe Fight Zone, Inc.$0.00+0.00%

CPYCFCompliance Energy Corporation

CPYCFCompliance Energy Corporation$0.00+0.00%

RNWBThe Renewable Corporation

RNWBThe Renewable Corporation$0.00+0.00%

GTCPGeorgetown Corporation

GTCPGeorgetown Corporation$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

INTCIntel

INTCIntel$108.77-0.06%

NOKNokia

NOKNokia$13.95-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

ONDSOndas

ONDSOndas$10.62-0.05%

Questions About KGET

What is the current price of CaliPharms?

CaliPharms is trading at N/A per share.

What is the 52-week range for CaliPharms?

Over the past 52 weeks, CaliPharms has traded between N/A and $0.01.

How much debt does CaliPharms have?

CaliPharms total debt is unavailable.

How much cash does CaliPharms have on hand?

CaliPharms does not have cash on hand data available.

What is CaliPharms’s dividend yield?

CaliPharms does not currently have a dividend yield.

CaliPharms

CaliPharms Financials at a Glance

KGET News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About CaliPharms

KGET Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

CaliPharms Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KGET

What is the current price of CaliPharms?

What is the 52-week range for CaliPharms?

How much debt does CaliPharms have?

How much cash does CaliPharms have on hand?

What is CaliPharms’s dividend yield?

Premium Investing Services